“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
“Sana’s Wearable Solution for Chronic Pain” Boulder, CO-based start-up Sana Health is taking on one of the biggest health crises in the world today: opioid use, as part of a larger mission to redefine the way pain is treated. Sana’s novel FlowState technology induces deep relaxation, promotes neuroplasticity, reduces pain, and triggers sleep in as little as 10 minutes. In this interview, Founder Richard Hanbury talks about his experiences in founding the company and what’s next for Sana Health.
In this week’s installment of our “MedTech History” series, we take a look at implantable neurostimulation/neuromodulation devices, which have their technical roots in cardiac pacing in the 1950s, but today are helping to restore function and improve quality of life for a growing list of serious neurological diseases and disorders. There have been a number of significant “firsts” in the space recently, including Cala Health’s FDA clearance for its Cala ONE neuromodulation therapy for transient relief of hand tremors in adults with essential tremor, and NeuroPace’s launch of its Next Gen RNS System, a brain-computer interface for the treatment of refractory epilepsy.